AR and prostate carcinoma: Studies have been identified that JMJD5 acts in the cyclin A1 coding region to regulate breast cancer cell proliferation [10], and as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in prostate cancer [12].